FLU SHOTS 100 YEARS AGO
Just for fun I decided
recently to peek at the contents of the JAMA from 100 years ago. As you might
expect several articles dealt with medical problems of WWI soldiers and several
with the 1918 influenza epidemic, also roaring through the military. What
caught my eye, though, was the attention paid to influenza vaccines.
Influenza was
believed by many to be caused by “Pfeiffer’s bacillus”, a small
fastidious rod
now considered to be the bacterium Hemophilus
influenzae. However, because Pfeiffer, a protégé of the great
bacteriologist Robert Koch, could not produce the illness in animals, and
because the bacillus turned up in other conditions and in normal throats, proof
of its causative role remained elusive. Brushing aside these uncertainties,
however, influenza vaccines hit the market rapidly and were aggressively
promoted.
Richard Pfeiffer (Wikipedia) |
The power of vaccination
was well known by then and several, such as smallpox, rabies, and typhoid, were
available. William Park, director of New York City Health Dept’s
laboratories,
who had already made diphtheria antitoxin and vaccine, made a three-dose
influenza vaccine from Pfeiffer’s bacillus, widely used in the military and by
industrial employees. A professor of bacteriology at Tufts Medical School,
Timothy Leary (not the marijuana guy), made another one, used in state
custodial institutions and on the private market. At the University of Pittsburg
Medical School a vaccine was created from 13 different strains of Pfeiffer
bacillus (employed by the Red Cross), at Tulane still another, and in New York
a private physician, Horace Greeley, made his from a cocktail of 17 strains.
William Park (Wikipedia) |
But was Pfeiffer’s bacillus really the
cause of influenza? More studies generated more uncertainty. Pneumococci and
streptococci were now turning up in greater numbers in sputum and lung samples
than Pfeiffer’s bacillus. Based on this, Edward Rosenow of the Mayo Clinic made
a vaccine from five different respiratory tract bacteria, including
pneumococci
and streptococci. It was distributed to the upper Midwest and manufactured by
the City of Chicago, where over 500,000 doses were produced.
Preparing Rosenow vaccine at Chicago Public Health Lab (from A Report on the Epidemic of Influenza in Chicago, 1918. Courtesy National Library of Medicine) |
Could all these
vaccines be effective? Most reports said they were, but sensible readers
realized that was impossible. Study design had been faulty in all but one case,
said William Park of New York and George McCoy of the US Public Health Service
in an important article. And that one exception failed to show any protective
effect. The missteps, they said, were giving vaccines without randomization,
using too few subjects, and starting the studies well after an epidemic begins.
Park and McCoy each performed their own studies, Park with employees of the
Metropolitan Life Insurance Co. and McCoy with inmates of a “state institution
for the insane” in California. Both studies began before the flu hit their
subjects, both ensured comparable study and control groups, and both employed
the Rosenow vaccine. Neither study showed any protective effect, thus setting important precedents for future vaccine trials. (True randomization and
blinding of experimenters were later developments. The first such trial was in
1943, evaluating a remedy for the common cold.)
George McCoy (NIH Almanac) |
That a filterable
agent might be the cause of influenza had occurred to only a few people during
the pandemic. One was Charles Nicolle, winner of the Nobel Prize for his
discovery of the louse as the vector of epidemic typhus. He reported
transmission of flu to monkeys and humans with submicroscopic filtrates of
sputum from flu sufferers. Eventually he and others with similar ideas were
proven to be correct, paving the way for modern flu vaccines.
HAPPY HOLIDAYS TO
ALL, AND DON’T FORGET YOUR FLU SHOT!
SOURCES:
Eyler,
John M. “The State of Science, Microbiology, and Vaccines Circa 1918”. Public Health Reports. 2010 suppl 3;
125: 27-36.
McCoy,
G W. “Pitfalls in Determining the Prophylactic or Curative Value of Bacterial
Vaccines” Public Health Reports 1919;
34(22): 1193-5.
Sholly,
A I and Park, W H. “Report on the Vaccination of 1536 Persons Against
Respirtory Diseases, 1919-20.” J
Immunology1921; 6: 103-16.
McCoy,
G W and Murray, V B. “The Failure of a Bacterial Vaccine as a Prophylactic
Against Influenza” 1918; JAMA
71(24):1997.
Nicolle,
Charles and Lebailly, Charles. “Recherches Expérimentales sur la Grippe” Annales de l’Institut Pasteur 1919; 33:
395-402.
Bhatt,
Arun. “Evolution of Clinical
Research: A History Before and Beyond James Lind” Perspect Clin Res 2010; 1(1): 6-10.